Skip to main
ALHC

Alignment Healthcare (ALHC) Stock Forecast & Price Target

Alignment Healthcare (ALHC) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 50%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Alignment Healthcare Inc is strategically positioned to capitalize on the stronger Medicare Advantage (MA) rate update in 2026, particularly as several managed care organizations (MCOs) are reducing their benefits, while Alignment benefits from a Stars funding advantage. The company’s integrated Medicare Advantage-Value-Based Care (MA-VBC) model is expected to support long-term market share gains and foster above-average growth prospects. Moreover, projected gross profit per member per month (PMPM) for the initial cohorts ranges from $90 to $150, with potential progression to over $230 PMPM in later years, indicating robust financial efficiency and growth potential.

Bears say

The financial analysis of Alignment Healthcare, Inc. reveals a concerning outlook primarily due to challenges linked to its value-based care model, which is hindered by data friction among various payors and difficulties in achieving consistent clinical outcomes. Although the company demonstrates a lower average daily cost per member (ADK) amidst increased healthcare utilization, this may not translate into sustainable financial performance as market dynamics shift. Furthermore, despite reporting above-average EBITDA growth and operating against public targets, the elevated valuation multiples compared to peer managed care organizations highlight a potential overvaluation, suggesting that investor expectations may not be aligned with underlying operational risks.

Alignment Healthcare (ALHC) has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 50% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alignment Healthcare (ALHC) Forecast

Analysts have given Alignment Healthcare (ALHC) a Buy based on their latest research and market trends.

According to 10 analysts, Alignment Healthcare (ALHC) has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alignment Healthcare (ALHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.